AMARYL MV 1 MG (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg))

AMARYL MV 1 MG is a combination medication designed to help manage blood sugar levels in individuals with type 2 diabetes. It supports patients by helping to improve their overall glycemic control when used alongside a balanced diet and regular exercise. This medication can assist in maintaining stable blood sugar levels, which is essential for overall health and reducing the risk of diabetes-related complications.

The active ingredients in AMARYL MV include Glimepiride, Metformin, and Voglibose. Glimepiride works by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels. Metformin primarily decreases the amount of sugar produced by the liver and enhances the sensitivity of muscle cells to insulin. Voglibose slows down the digestion of carbohydrates, leading to a more gradual rise in blood sugar after meals.

For best results, store this medication in a cool, dry place away from direct sunlight. Consistency in use is important for effective management of diabetes. Patients should be aware of general precautions, including regular monitoring of blood sugar levels and maintaining a healthy lifestyle.

Common side effects may include mild gastrointestinal discomfort, such as gas, bloating, or diarrhea. These effects usually lessen over time.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.